Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
glp 1 agonists and inflammation The cardiovascular effects of GLP-1 receptor beyond obesity type 2 diabetes: An anti-atherosclerotic action Visibility - All Size:120 Pfizer snaps up rights
Pfizer snaps up rights to commercialize diabetes GLP-1 in China
Lilly also hopes to have an anti-obesity pill approved sometime next year
Visibility - All
Size:120
Göke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Göke B
US$ 20.51
US$ 27.88
US$ 20.36
US$ 26.71
US$ 27.14
